Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174344
A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The implementation of immunotherapy has radically changed the treatment of oncological patients. Currently, immunotherapy is indicated in the treatment of patients with head and neck tumors, melanoma, lung cancer, bladder tumors, colon cancer, cervical cancer, breast cancer, Merkel cell carcinoma, liver cancer, leukemia and lymphomas. However, its efficacy is restricted to a limited number of cases. The challenge is, therefore, to identify which subset of patients would benefit from immunotherapy. To this end, the establishment of immunotherapy response criteria and predictive and prognostic biomarkers is of paramount interest. In this report, a group of experts of the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Medical Radiology (SERAM), and Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM) provide an up-to-date review and a consensus guide on these issues.
Matèries
Matèries (anglès)
Citació
Citació
LEON MATEOS, L., GARCIA VELLOSO, M. j., GARCÍA FIGUEIRAS, R., RODRIGUEZ MORENO, J. f., VERCHER CONEJERO, José luís, SÁNCHEZ, M., PÉREZ GRACIA, José luis, SIMO PERDIGO, M., GOROSPE, L.. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment. _Clinical and Translational Oncology_. 2020. [consulta: 27 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/174344]